|
|
||||||||
Graduate School of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee 37920, USA
Reprint requests to: Dr. Ronald Wetzel, Graduate School of Medicine, R221 University of Tennessee Medical Center, 1924 Alcoa Highway, Knoxville, TN 37920, USA; e-mail rwetzel{at}mc.utmck.edu; fax (865) 544-9235.
A method is described for dissolving and disaggregating chemically synthesized polyglutamine peptides. Polyglutamine peptides longer than about Q20 have been reported to be insoluble in water, but dissolution in and evaporation from - a mixture of trifluoroacetic acid and hexafluoroisopropanol converts polyglutamine peptides up to at least Q44 to a form readily soluble in aqueous buffers. This procedure also has a dramatic effect on peptides which appear to be completely soluble in water, by removing traces of aggregate that seed aggregation. The protocol makes possible solution studiesincluding in vitro aggregation experimentson polyglutamine peptides with repeat lengths associated with increased risk of Huntington's Disease and other expanded CAG repeat diseases. It may also be useful in conducting reproducible, quantitative aggregation studies on other polypeptides.
Keywords: Polyglutamine; disaggregation; nucleation-dependent aggregation; seed; Huntington's disease
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
X. Wang, D. R. Smith, J. W. Jones, and M. R. Chapman In Vitro Polymerization of a Functional Escherichia coli Amyloid Protein J. Biol. Chem., February 9, 2007; 282(6): 3713 - 3719. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Crick, M. Jayaraman, C. Frieden, R. Wetzel, and R. V. Pappu Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions PNAS, November 7, 2006; 103(45): 16764 - 16769. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Nguyen, P. Kobbe, H. Rahne, T. Worpel, B. Jager, M. Stephan, R. Pabst, C. Holzmann, O. Riess, H. Korr, et al. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease Hum. Mol. Genet., November 1, 2006; 15(21): 3177 - 3194. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Slepko, A. M. Bhattacharyya, G. R. Jackson, J. S. Steffan, J. L. Marsh, L. M. Thompson, and R. Wetzel Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins PNAS, September 26, 2006; 103(39): 14367 - 14372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Marchut and C. K. Hall Side-Chain Interactions Determine Amyloid Formation by Model Polyglutamine Peptides in Molecular Dynamics Simulations Biophys. J., June 15, 2006; 90(12): 4574 - 4584. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Malavolta, M. R.S. Pinto, J. H. Cuvero, and C. R. Nakaie Interpretation of the dissolution of insoluble peptide sequences based on the acid-base properties of the solvent. Protein Sci., June 1, 2006; 15(6): 1476 - 1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arango, S. Holbert, D. Zala, E. Brouillet, J. Pearson, E. Regulier, A. K. Thakur, P. Aebischer, R. Wetzel, N. Deglon, et al. CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J. Neurosci., April 26, 2006; 26(17): 4649 - 4659. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shivaprasad and R. Wetzel Scanning Cysteine Mutagenesis Analysis of Abeta-(1-40) Amyloid Fibrils J. Biol. Chem., January 13, 2006; 281(2): 993 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Slow, R. K. Graham, A. P. Osmand, R. S. Devon, G. Lu, Y. Deng, J. Pearson, K. Vaid, N. Bissada, R. Wetzel, et al. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions PNAS, August 9, 2005; 102(32): 11402 - 11407. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hortschansky, V. Schroeckh, T. Christopeit, G. Zandomeneghi, and M. Fandrich The aggregation kinetics of Alzheimer's {beta}-amyloid peptide is controlled by stochastic nucleation Protein Sci., July 1, 2005; 14(7): 1753 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Finke, M. S. Cheung, and J. N. Onuchic A Structural Model of Polyglutamine Determined from a Host-Guest Method Combining Experiments and Landscape Theory Biophys. J., September 1, 2004; 87(3): 1900 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O'Nuallain, A. D. Williams, P. Westermark, and R. Wetzel Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils J. Biol. Chem., April 23, 2004; 279(17): 17490 - 17499. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hirota-Nakaoka, K. Hasegawa, H. Naiki, and Y. Goto Dissolution of {beta}2-Microglobulin Amyloid Fibrils by Dimethylsulfoxide J. Biochem., July 1, 2003; 134(1): 159 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sen, D. Dash, S. Pasha, and S. K. Brahmachari Role of histidine interruption in mitigating the pathological effects of long polyglutamine stretches in SCA1: A molecular approach Protein Sci., May 1, 2003; 12(5): 953 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruoppolo, S. Orru, S. Francese, I. Caputo, and C. Esposito Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats Protein Sci., January 1, 2003; 12(1): 170 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Thakur and R. Wetzel Mutational analysis of the structural organization of polyglutamine aggregates PNAS, December 24, 2002; 99(26): 17014 - 17019. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, J. R. Dunlap, R. B. Andrews, and R. Wetzel Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells Hum. Mol. Genet., November 1, 2002; 11(23): 2905 - 2917. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, F. A. Ferrone, and R. Wetzel Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation PNAS, September 3, 2002; 99(18): 11884 - 11889. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O'Nuallain and R. Wetzel Conformational Abs recognizing a generic amyloid fibril epitope PNAS, January 24, 2002; (2002) 22662599. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O'Nuallain and R. Wetzel Conformational Abs recognizing a generic amyloid fibril epitope PNAS, February 5, 2002; 99(3): 1485 - 1490. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |